Interpace Biosciences Inc (IDXG)
1.422
-0.13
(-8.34%)
USD |
OTCM |
Apr 25, 16:00
Interpace Biosciences Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.976M |
| March 31, 2023 | -5.305M |
| December 31, 2022 | -7.692M |
| September 30, 2022 | -8.634M |
| June 30, 2022 | -6.066M |
| March 31, 2022 | -4.967M |
| December 31, 2021 | -8.719M |
| September 30, 2021 | -9.085M |
| June 30, 2021 | -14.13M |
| March 31, 2021 | -11.86M |
| December 31, 2020 | -13.98M |
| September 30, 2020 | -18.80M |
| June 30, 2020 | -17.84M |
| March 31, 2020 | -23.12M |
| December 31, 2019 | -18.96M |
| September 30, 2019 | -14.43M |
| June 30, 2019 | -11.43M |
| March 31, 2019 | -9.139M |
| December 31, 2018 | -8.673M |
| September 30, 2018 | -9.179M |
| June 30, 2018 | -11.72M |
| March 31, 2018 | -13.61M |
| December 31, 2017 | -15.26M |
| September 30, 2017 | -13.87M |
| June 30, 2017 | -10.91M |
| Date | Value |
|---|---|
| March 31, 2017 | -7.786M |
| December 31, 2016 | -7.607M |
| September 30, 2016 | -12.92M |
| June 30, 2016 | -16.97M |
| March 31, 2016 | -18.20M |
| December 31, 2015 | -19.84M |
| September 30, 2015 | -21.95M |
| June 30, 2015 | -16.23M |
| March 31, 2015 | -15.53M |
| December 31, 2014 | -16.38M |
| September 30, 2014 | -11.72M |
| June 30, 2014 | -11.23M |
| March 31, 2014 | -11.20M |
| December 31, 2013 | -3.512M |
| September 30, 2013 | -6.894M |
| June 30, 2013 | -4.019M |
| March 31, 2013 | -6.714M |
| December 31, 2012 | -10.29M |
| September 30, 2012 | -4.255M |
| June 30, 2012 | -6.423M |
| March 31, 2012 | -2.12M |
| December 31, 2011 | 1.985M |
| September 30, 2011 | 6.972M |
| June 30, 2011 | 8.443M |
| March 31, 2011 | 17.17M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-23.12M
Minimum
Mar 2020
-1.976M
Maximum
Jun 2023
-11.59M
Average
-11.43M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
| Fonar Corp | 15.29M |
| XWELL Inc | -16.07M |
| ProPhase Labs Inc | -11.35M |
| Applied DNA Sciences Inc | -7.592M |
| Veracyte Inc | 44.22M |